Automated ELISA analyzers

01Overview and value chain#

Markers EC: US FDA CLIA + IVDR (EU) 2017/746 for automated immunoassay analyzer classification | OECD: Bio-pharmaceuticals | Regulator: FDA (USA), EMA (EU), NMPA (China)

Automated ELISA analyzers integrate every step of the enzyme-linked immunosorbent assay workflow — sample dilution, reagent and substrate dispensing, timed incubation, plate washing and photometric absorbance reading — into a single walk-away instrument run, replacing a manual process that otherwise demands a technician’s continuous attention across a multi-hour protocol. The category spans clinical diagnostics laboratories running infectious-disease and autoimmune panels, blood-establishment donor-screening labs, and biopharma QC labs running potency, immunogenicity or anti-drug-antibody assays on the same underlying microplate chemistry. Instruments differ mainly in throughput architecture and degree of closure: some process one plate at a time through a fully enclosed cabinet with integrated washing and reading, while others use a modular liquid-handling deck that can be reconfigured across different assay protocols. The shared value proposition across all formats is the same — standardized, operator-independent timing at every wash and incubation step removes the largest source of inter-run variability in manual ELISA, directly improving assay reproducibility.

The key directions of automated ELISA analysis are:

1. Closed, integrated ELISA workstations (Closed Workstations): fully enclosed cabinet instruments that carry a microplate through the entire dispense-incubate-wash- read cycle without user intervention, the standard for high-volume clinical and blood-screening labs.
2. Modular liquid-handling ELISA automation (Modular Automation): deck-based systems that automate plate handling and reagent dispensing but retain flexibility to reconfigure across different assay protocols and plate formats.
3. Random-access and continuous-loading systems (Random Access): platforms that accept new sample racks mid-run rather than requiring a full batch to complete first, maximizing daily throughput in high-volume labs.
4. Walk-away QC/potency assay automation (Biopharma QC Automation): ELISA automation adapted specifically for GxP-regulated biopharma potency, immunogenicity and anti-drug-antibody testing, with 21 CFR Part 11-compliant audit trails.

Sectoral value chain#

[Sample + reagents] ──> [Automated dispensing] ──> [Incubation & washing cycles] ──> [Photometric reading]
                                                                  │
                                                          (result calculation)
                                                                  │
                                                                  ▼
[Diagnostic/QC report] <─── [Software: standard-curve fitting, cutoff determination]

Value chain levels#

Cross-cutting technologies of the sector:

• Barcode-driven sample tracking: automated readers scan sample and reagent barcodes to eliminate manual transcription error across the multi-step ELISA protocol.
• Multi-wavelength photometric detection: dual-wavelength absorbance reading corrects for plate-bottom optical artifacts, improving result precision versus single-wavelength reading.
• LIS/LIMS bidirectional connectivity: newer instruments increasingly integrate directly with laboratory information systems for order download and automated result upload, cutting manual data entry.

02US#

The US hosts a long-standing dedicated ELISA-automation specialist, positioned across clinical, research and blood-screening laboratories of varying scale.

dedicated ELISA processing automation, next-generation walk-away platforms, clinical/research lab deployment#

• DYNEX Technologies: the DS2 Elite, introduced as the next generation of the established DS2 automated ELISA processing platform, is positioned to elevate laboratory performance for fully automated ELISA processing across laboratories and research clinics of all sizes.

03CN#

Autobio Diagnostics is a confirmed China-headquartered vendor in this category, one of the few EQP-kind screens this session to clear with a domestic instrument maker rather than an import-only market.

domestic automated-ELISA manufacturing, public-tender-documented deployment, IVD-registered instruments#

• Autobio Diagnostics (Zhengzhou): a major Chinese in-vitro-diagnostics manufacturer, confirmed through government procurement tender records for automated ELISA workstation maintenance service and device-registration documentation for its automated immunoassay instrument line, evidencing a real, deployed domestic installed base.
• Screening note: evidence for this entity came primarily from Chinese government procurement tender listings and a device-registration record rather than the vendor’s own marketing pages, so specification claims are kept general rather than citing exact performance numbers.

04EU#

Italy and Spain both host established diagnostics manufacturers whose automated ELISA platforms serve clinical and blood-screening laboratories across Europe and beyond.

microtiter-plate full-process automation, blood-establishment donor-screening platforms, clinical immunoassay analyzers#

• DiaSorin (Italy): the ETI-MAX 3000 fully automated microplate analyzer performs the complete ELISA sample-processing workflow on a single closed instrument, an established platform still actively traded on the secondary clinical-equipment market.
• Grifols (Spain): the Triturus immunoassay analyzer automates ELISA-format testing, positioned within Grifols’s broader blood-and-plasma diagnostics portfolio alongside its immunohematology sample-processing systems.

05Leading companies and research institutes#

06Tech stack and innovations#

The stack layers robotic liquid handling, timed incubation/wash cycles and photometric detection on a common result-calculation software backbone, with the choice between closed and modular architectures driven by throughput needs and assay-protocol flexibility.

1. Closed-cabinet full-process automation:
   • An integrated instrument carries the microplate through dispensing, incubation, washing and reading without operator intervention, minimizing hands-on time and inter-operator variability.
   • Suited to high-volume clinical and blood-screening labs running standardized assay panels repeatedly.
2. Modular liquid-handling deck automation:
   • A reconfigurable pipetting deck automates dispensing and washing while retaining flexibility to accommodate different plate formats and assay protocols.
   • Better suited to research or reference labs running varied, less-standardized assay menus than a single dedicated clinical panel.
3. Barcode-driven tracking and LIS/LIMS integration:
   • Automated barcode scanning of samples and reagents throughout the run eliminates manual transcription steps that are a common source of ELISA workflow error.
   • Direct LIS/LIMS connectivity for order download and result upload reduces manual data entry and supports audit-trail completeness in regulated environments.

07Value chains and production pipelines#

Industrial pipeline of an automated ELISA diagnostic/QC run (CLIA / IVDR)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Sample/reagent loading  │ ───> │ 2. Automated dispensing     │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Photometric reading     │ <─── │ 3. Incubation & washing     │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Result calculation      │ ───> │ 6. Diagnostic/QC report    │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Sample and reagent loading

Patient samples, controls and assay-specific reagent kits are loaded onto the instrument’s deck or carousel, with barcode scanning confirming correct sample and reagent identification.

Stage 2: Automated dispensing

Robotic pipetting dispenses diluted sample, enzyme-conjugated antibody and substrate into microplate wells according to the loaded assay protocol.

Stage 3: Incubation and washing

The plate incubates at controlled temperature for defined periods specific to each assay step, with automated washing cycles removing unbound reagent between additions.

Stage 4: Photometric reading

An integrated plate reader measures absorbance at the assay’s specified wavelength (or dual wavelengths for optical-artifact correction) for every well on the plate.

Stage 5: Result calculation

Software fits a standard curve or applies a cutoff-based algorithm to convert raw absorbance values into a quantitative concentration or a qualitative positive/negative call for each sample.

Stage 6: Diagnostic or QC report

Results are compiled into a diagnostic report for clinical use or a GxP-compliant QC record for biopharma potency/immunogenicity testing, with LIS/LIMS-compatible data export.